1.3 / April 29, 2012
(that patients treated with rt-PA were also more likely to<br>have minimal or no disability at one-year follow-up.</div> <div class="show-more-end" jsaction="click:vhaaFf"></div> </div> </div> <div> <button class="play-button show-more small" jsaction="KoToPc"> Read more </button> <button class="play-button expand-close" jsaction="vhaaFf"> <div class="close-image"> </div> </button> </div> </div> <div class="details-section-divider"></div> </div> </div> </div> <div class="details-wrapper"> <div class="details-section whatsnew"> <div class="details-section-contents show-more-container" jscontroller="G7YeLc" jsaction="rcuQ6b:rcuQ6b"> <h1 class="heading"> What's New </h1> <div class="recent-change">1.Rt-PA dosing calculator</div><div class="recent-change">2.Pounds or Kilogram transferring calculation</div><div class="recent-change">3.Case registry with database concept</div><div class="recent-change">4.Fast-approaching your patient with the rt-PA dosage</div><div class="recent-change">5.User-friendly interface</div><div class="recent-change">6.Saving and retrieving database</div><div class="recent-change">7.Rt-PA administrated reference</div> <div class="show-more-end" jsaction="click:vhaaFf"></div> <div> <button class="play-button show-more small" jsaction="KoToPc"> Read more </button> <button class="play-button expand-close" jsaction="vhaaFf"> <div class="close-image"> </div> </button> </div> </div> <div class="details-section-divider"></div> </div> </div> <div class="details-wrapper"> <div class="details-section metadata"> <div class="details-section-heading"> <h1 class="heading"> Additional information </h1> </div> <div class="details-section-contents"> <div class="meta-info"> <div class="title">Updated</div> <div class="content" itemprop="datePublished">April 29, 2012</div> </div> <div class="meta-info"> <div class="title">Size</div> <div class="content" itemprop="fileSize"> 727k </div> </div> <div class="meta-info"> <div class="title">Installs</div> <div class="content" itemprop="numDownloads"> 10 - 50 </div> </div> <div class="meta-info"> <div class="title">Current Version</div> <div class="content" itemprop="softwareVersion"> 1.3 </div> </div> <div class="meta-info"> <div class="title">Requires Android</div> <div class="content" itemprop="operatingSystems"> 2.3.3 and up </div> </div> <div class="meta-info contains-text-link"> <div class="title">Content Rating</div> <div class="content" itemprop="contentRating">Unrated</div> <div class="content">Warning – content has not yet been rated. Unrated apps may potentially contain content appropriate for mature audiences only.</div> <a class="content" href="https://support.google.com/googleplay?p=appgame_ratings" target="_blank">Learn more</a> </div> <div class="meta-info"> <div class="title">Permissions</div> <button class="content id-view-permissions-details fake-link" data-docid="rtpastroke.com"> View details </button> </div> <div class="meta-info contains-text-link"> <div class="title">Report</div> <a class="content" href="https://support.google.com/googleplay/?p=report_content" target="_blank"> Flag as inappropriate </a> </div> <div class="meta-info"> <div class="title"> Offered By </div> <div class="content">Ho Hsuhua</div> </div> <div class="meta-info"> <div class="title"> Developer </div> <div class="content contains-text-link"> <a class="dev-link" href="https://www.google.com/url?q=http://www.neurovisit.com/&sa=D&usg=AFQjCNFzWNL_9BFOzwLrgfP1oY2W8PA4kg" rel="nofollow" target="_blank"> Visit website </a> <a class="dev-link" href="mailto:[email protected]" rel="nofollow" target="_blank"> Email [email protected] </a> </div> </div> </div> <div class="details-section-divider"></div> </div> </div><div class="details-wrapper"> <div class="id-cluster-container details-section recommendation"> <div class="details-section-contents"> <div class="rec-cluster" data-server-cookie="CAMiHggCEAMaFhIUCg5ydHBhc3Ryb2tlLmNvbRABGAMoAQ==" data-uitype="400"> <h1 class="heading"> Similar </h1> <div class="cards expandable id-card-list"> <div class="card no-rationale square-cover apps small" data-docid="appinventor.ai_cubicturtle.PocketNIHSS" data-original-classes="card no-rationale square-cover apps small" data-short-classes="card no-rationale square-cover apps tiny" data-thin-classes="card no-rationale square-cover apps small"> <div class="card-content id-track-click id-track-impression" data-docid="appinventor.ai_cubicturtle.PocketNIHSS" data-server-cookie="CAIaMgouEiwKJmFwcGludmVudG9yLmFpX2N1YmljdHVydGxlLlBvY2tldE5JSFNTEAEYA0IA" data-uitype="500"> <a class="card-click-target" data-server-cookie="CAIaMgouEiwKJmFwcGludmVudG9yLmFpX2N1YmljdHVydGxlLlBvY2tldE5JSFNTEAEYA0IA" data-uitype="500" href="/store/apps/details?id=appinventor.ai_cubicturtle.PocketNIHSS" aria-hidden="true" tabindex="-1"></a> <div class="cover"> <div class="cover-image-container"> <div class="cover-outer-align"> <div class="cover-inner-align"> <img alt="Pocket NIHSS" class="cover-image" data-cover-large="https://lh6.ggpht.com/aMeru_6VZgxNHgl9lbYnTt2YrC-cugm6YweSisYG74kTuJ2hDx0emxFb7WEOPBE9lbHP=w340" data-cover-small="https://lh6.ggpht.com/aMeru_6VZgxNHgl9lbYnTt2YrC-cugm6YweSisYG74kTuJ2hDx0emxFb7WEOPBE9lbHP=w170" src="https://lh6.ggpht.com/aMeru_6VZgxNHgl9lbYnTt2YrC-cugm6YweSisYG74kTuJ2hDx0emxFb7WEOPBE9lbHP=w170" aria-hidden="true"> </div> </div> </div> <a class="card-click-target" href="/store/apps/details?id=appinventor.ai_cubicturtle.PocketNIHSS" aria-label=" Pocket NIHSS "> <span class="movies preordered-overlay-container id-preordered-overlay-container" style="display:none"> <span class="preordered-label"> Pre-ordered </span> </span> <span class="preview-overlay-container" data-docid="appinventor.ai_cubicturtle.PocketNIHSS"> </span> </a> </div> <div class="details"> <a class="card-click-target" href="/store/apps/details?id=appinventor.ai_cubicturtle.PocketNIHSS" aria-hidden="true" tabindex="-1"> </a> <a class="title" href="/store/apps/details?id=appinventor.ai_cubicturtle.PocketNIHSS" title="Pocket NIHSS" aria-hidden="true" tabindex="-1"> Pocket NIHSS <span class="paragraph-end"></span> </a> <div class="subtitle-container"> <a class="subtitle" href="/store/apps/developer?id=CubicTurtle" title="CubicTurtle">CubicTurtle</a> <span class="price-container"> <span class="paragraph-end"></span> <span class="apps is-price-tag buy-button-container is_not_aquired_or_preordered" data-doc-fetch-skip-cache="0" data-doc-fetch-vouchers="0" data-docid="appinventor.ai_cubicturtle.PocketNIHSS"> <div class="pon" style="display:none">1</div> <button class="price buy id-track-click id-track-impression" data-server-cookie="CAIaMgouEiwKJmFwcGludmVudG9yLmFpX2N1YmljdHVydGxlLlBvY2tldE5JSFNTEAEYA0IA" data-uitype="200"> <span class="display-price">$0.99</span> </button> </span> </span> </div> <div class="description"> Quickly calculate the NIH Stroke Scale for your patients with this reference <span class="paragraph-end"></span> <a class="card-click-target" href="/store/apps/details?id=appinventor.ai_cubicturtle.PocketNIHSS" aria-hidden="true" tabindex="-1"> </a> </div> </div> <div class="reason-set"> <span class="stars-container"> <a href="/store/apps/details?id=appinventor.ai_cubicturtle.PocketNIHSS"> <div class="reason-set-star-rating"> <div class="tiny-star star-rating-non-editable-container" aria-label=" Rated 4.4/5) ()

Description

In 1995, the National Institute ofNeurologicalDisorders and Stroke (NINDS) study group reported thatpatients withacute ischemic stroke who received alteplase withinthreehours
after the onset of symptoms were at least 30% more likely tohaveminimal or no disability at three months than those whoreceivedplacebo. A subsequent study demonstrated that patientstreated withrt-PA were also more likely to
have minimal or no disability at one-year follow-up.

App Information rt-PA Dosing Calculator

  • App Name
    rt-PA Dosing Calculator
  • Package Name
    rtpastroke.com
  • Updated
    April 29, 2012
  • File Size
    727k
  • Requires Android
    Android 2.3.3 and up
  • Version
    1.3
  • Developer
    Ho Hsuhua
  • Installs
    10 - 50
  • Price
    $1.00
  • Category
    Medical
  • Developer
  • Google Play Link

Ho Hsuhua Show More...

Clinical Lab (LDL calculator) 1.4 APK
Ho Hsuhua
Low-density lipoprotein (LDL) is one of thefive major groups of lipoproteins, which in order of size, largestto smallest, are chylomicrons, VLDL, IDL, LDL, and HDL, that enabletransport of multiple different fat molecules, includingcholesterol, within the water around cells and within thewater-based bloodstream. Studies have shown that higher levels oftype-B LDL particles promote health problems and cardiovasculardisease, they are often informally called the bad cholesterolparticles, (as opposed to HDL particles, which are frequentlyreferred to as good cholesterol or healthy cholesterolparticles).
Clinical Lab ( Gault GFR ) 1.0 APK
Ho Hsuhua
Renal function is an indication of the stateof the kidney and its role in renal physiology. Glomerularfiltration rate (GFR) describes the flow rate of filtered fluidthrough the kidney. Creatinine clearance rate (CCr or CrCl) is thevolume of blood plasma that is cleared of creatinine per unit timeand is a useful measure for approximating the GFR. A commonly usedsurrogate marker for estimate of creatinine clearance is theCockcroft-Gault formula, which in turn estimates GFR in ml/min. Itis named after the scientists who first published the formula, andit employs serum creatinine measurements and a patient's weight topredict the creatinine clearance.
NIHSS ( Stroke Scales ) 1.3 APK
Ho Hsuhua
The NIHSS is a 15-item neurologic examinationstroke scale used to evaluate the effect of acute cerebralinfarction on the levels of consciousness, language, neglect,visual-field loss, extraocular movement, motor strength, ataxia,dysarthria, and sensory loss.
Modified Rankin Stroke scale 1.3 APK
Ho Hsuhua
The modified Rankin scale is a 6 pointdisability scalewith possible scores ranging from 0 up to 5. A separate category(of 6) is sometimes added for patients who die. The modified Rankinscale has been used widely in both secondary prevention and acutestroke trials,including most of the thrombolysis trials.In order todetect a treatment effect or to demonstrate clinical improvement,it is important that patients are rated in a consistent manner,minimising variability.
Clinical Lab ( GFR ) 1.0 APK
Ho Hsuhua
In adults, the best equation for estimatingglomerular filtration rate (GFR) from serum creatinine is theisotope dilution mass spectrometry (IDMS)-traceable Modification ofDiet in Renal Disease (MDRD) Study equation1. All laboratories areusing creatinine methods calibrated to be IDMS traceable.
NIHSS(中文版脑中风量表) 1.0 APK
Ho Hsuhua
NIHSS是美国国卫院所建立对于脑中风病人整体严重度的客观评估标准,可用于筛选适合施打rt-PA之病人,太严重(超过26分)及太轻微(不足4分)之病人都不适合施打。此中风量表是在1980年代,为缺血性脑中风治疗之临床研究计划,所设计出来的一个标准化神经学检查量表(Goldstein LB, et al. Arch Neurol 1989)。目前经常作为缺血性脑中风时药物治疗与临床预后的量化评估工具。
Levophed Infusion Rate 1.0 APK
Ho Hsuhua
Individualized dosage. Administer as dilutedIV infusion. Levophed SF Initial dose: 2-3 mL/min. Ave maintenancedose: 0.5-1 mL/min.
Clinical Lab (HCO3 Deficiency) 1.0 APK
Ho Hsuhua
Bicarbonate Deficits CalculatorBicarbonate Deficit is condition caused by excessiveorganic or inorganic acids in the body.The excess may be due to abnormally high acid productionwhich arises during fever and starvation or loss of bases.This calculator is used to calculate HCO3- deficits in patientswith metabolic acidosis.